AVALANCHE BIOTECHNOLOGIES IN's ticker is AAVL and the CUSIP is 05337G107. A total of 94 filers reported holding AVALANCHE BIOTECHNOLOGIES IN in Q3 2015. The put-call ratio across all filers is 2.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $2,795,000 | +50.4% | 540,632 | +177.1% | 0.14% | +37.3% |
| Q4 2015 | $1,858,000 | -60.7% | 195,132 | -66.0% | 0.10% | -47.7% |
| Q3 2015 | $4,732,000 | +47.3% | 574,260 | +190.3% | 0.20% | +66.7% |
| Q2 2015 | $3,212,000 | +44.3% | 197,800 | +260.0% | 0.12% | +25.8% |
| Q1 2015 | $2,226,000 | -71.1% | 54,943 | -61.5% | 0.09% | -61.9% |
| Q4 2014 | $7,711,000 | +350.9% | 142,803 | +185.6% | 0.24% | +269.7% |
| Q3 2014 | $1,710,000 | – | 50,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|